Мальта - английский - Medicines Authority

wockhardt uk limited - furosemide - tablet - furosemide 40 mg - diuretics

Мальта - английский - Medicines Authority

wockhardt uk limited - furosemide - solution for injection/infusion - furosemide 10 mg/ml - diuretics

Мальта - английский - Medicines Authority

wockhardt uk limited - furosemide - solution for injection/infusion - furosemide 10 mg/ml - diuretics

Австралия - английский - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - furosemide, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; sodium chloride - oedema: furosemide-baxter injection is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. furosemide-baxter injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous route. parenteral use should be replaced with oral frusemide as soon as practical.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - furosemide, quantity: 20 mg - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid - oedema: furosemide-baxter injection is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. furosemide-baxter injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous route. parenteral use should be replaced with oral frusemide as soon as practical.

Великобритания - английский - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - furosemide - oral tablet - 20mg

Мальта - английский - Medicines Authority

accord healthcare limited - furosemide - solution for injection - furosemide 10 mg/ml - diuretics

Мальта - английский - Medicines Authority

accord healthcare limited - furosemide - solution for injection - furosemide 10 mg/ml - diuretics

Мальта - английский - Medicines Authority

accord healthcare limited - furosemide - solution for injection - furosemide 10 mg/ml - diuretics

Мальта - английский - Medicines Authority

accord healthcare limited - furosemide - solution for injection - furosemide 10 mg/ml - diuretics